WILMINGTON, N.C., Feb. 26 /PRNewswire-FirstCall/ --
aaiPharma Inc. (Nasdaq: AAII) today announced that Dr. Frederick D.
Sancilio, Executive Chairman and Chief Scientific Officer of aaiPharma, will
be presenting at the Salomon Smith Barney 3rd Annual Specialty Pharmaceuticals
Conference on Wednesday, March 5, at 9:20 AM (EST). The conference is being
held in New York City.
The presentation will be webcast live over the Internet, then archived and
available for 10 days following the event. The audio and slide presentation
web cast will be accessible through the Company's website at
http://www.aaipharma.com.
About aaiPharma
aaiPharma Inc. is a science-based specialty pharmaceutical company
headquartered in Wilmington, North Carolina with more than 23 years of drug
development experience. In addition to developing and marketing its own line
of proprietary pharmaceutical products, aaiPharma continues to be a world
leader in providing contract pharmaceutical development services through its
AAI International division. For more information on the Company, please visit
the website at http://www.aaipharma.com.
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
Mr. James B. Sloan, Jr., Senior Vice
President of Corporate Finance of aaiPharma Inc., +1-910-254-7690
|
